News | Women's Health | August 17, 2015

Regional Node Irradiation Beneficial for Stage I-III Breast Cancer Patients

European study finds overall survival improved at 10-year follow-up

breast cancer, stage I-III, irradiation, regional nodes, EORTC, Philip Poortmans

Ryan Tobin Photography for Densitas Inc.

August 17, 2015 — Patients with stage I, II or III breast cancer see marginal benefit on overall survival with irradiation of regional nodes, according to a new study from the European Organisation for Research and Treatment of Cancer (EORTC). Conducted at a median follow-up of 10.9 years, the study found that overall survival was 82.3 percent for regional irradiation versus 80.7 percent for no regional irradiation (HR=0.87 (95%CI: 0.76, 1.00), p=0.06).

The results, published in the New England Journal of Medicine, also showed that disease-free survival, distant-disease-free survival and breast cancer mortality were significantly improved. Side effects were very limited, although very long-term toxicity of radiation remains unknown.

The phase III EORTC 22922-10925 trial was conducted to evaluate what effect regional node irradiation — i.e., irradiation of the internal mammary and medial supraclavicular lymph nodes — would add to whole breast or chest wall irradiation following surgery in patients with stage I, II, and III breast cancer.

Prof. Philip Poortmans of the Radboud university medical center, Nijmegen, The Netherlands said: "We became interested in the role that elective regional radiation therapy might play following the publication of several studies that showed conflicting results of this treatment: one, an increased long-term mortality due to cardiac causes following outdated irradiation techniques; two, that loco-regional post-mastectomy radiation therapy had a favorable effect on disease-related endpoints; and three, that improved irradiation techniques led to lower cardiac exposure. Therefore, our study was highly needed to address the existing uncertainties concerning the role of lymph node irradiation. The results are very important as they show a clinically relevant decrease in distant-disease-free and disease-free survival, which points to the fact that the effect of radiation therapy should not only be measured by the influence on loco-regional control. Moreover, we expect that the currently modest benefit on overall survival will increase with longer follow-up, especially as we did not at all see any increase in other causes of death than cancer after regional irradiation."

From 1996 through 2004, this randomized trial coordinated by the EORTC Radiation Oncology and Breast Cancer Groups accrued 4,004 patients with either positive axillary lymph nodes or, in the case of tumor-free lymph nodes, centrally or medially located primary tumors. The investigators concluded that regional irradiation does benefit patients with early stage breast cancer, but they also point out that these data are not applicable to patients with laterally located node-negative cancers, the largest patient subgroup in industrialized countries. They plan to continue trial monitoring for up to 20 years median follow-up.

For more information: www.eortc.org

Related Content

Stereotactic Radiosurgery Effective for Pediatric Arteriovenous Malformation Patients
News | Radiation Therapy | April 19, 2019
Ching-Jen Chen, M.D., of the neurosurgery department at the University of Virginia (UVA) Health System, was the winner...
Video Plus Brochure Helps Patients Make Lung Cancer Scan Decision

Image courtesy of the American Thoracic Society

News | Lung Cancer | April 19, 2019
A short video describing the potential benefits and risks of low-dose computed tomography (CT) screening for lung...
In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images

In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images. Photo by Greg Freiherr

Feature | Artificial Intelligence | April 19, 2019 | By Greg Freiherr
Commercial efforts to develop...
Videos | Breast Imaging | April 18, 2019
In a keynote lecture at the Society of Breast Imaging (SBI)/American College of Radiology (ACR) 2019 Symposium, ...
Surgically Guided Brachytherapy Improves Outcomes for Intracranial Neoplasms
News | Brachytherapy Systems | April 18, 2019
Peter Nakaji, M.D., FAANS, general practice neurosurgeon at Barrow Neurological Institute, presented new research on...
Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer

Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer. Permission to publish provided by DenseBreast-info.org

Feature | Breast Imaging | April 18, 2019 | By Greg Freiherr
When planning a screening program to detect the early signs of breast cancer, age is a major consideration.
iCAD Appoints Stacey Stevens as President
News | Radiology Business | April 16, 2019
iCAD Inc. recently announced that Stacey Stevens has been named president. As president, Stevens will have expanded...
compressed breast during mammography.
360 Photos | 360 View Photos | April 16, 2019
A 360 view of a simulated breast compression for a...
ASTRO Applauds Introduction of PIMA Patient Protection Bill
News | Radiology Business | April 15, 2019
The American Society for Radiation Oncology (ASTRO) hailed the introduction of federal legislation that would...